Rheumatoid arthritis Trials in Lake Charles, United States
Conditions / Rheumatoid arthritis / Lake Charles, United States
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00717236 | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01636843 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate | TERMINATED | PHASE2 |
| NCT01764997 | An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate | TERMINATED | PHASE3 |
| NCT03915964 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT01636817 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics | TERMINATED | PHASE2 |
| NCT04086745 | A Study of Baricitinib in Participants With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT01709578 | To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) | COMPLETED | PHASE3 |
| NCT06972446 | A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis | RECRUITING | — |
| NCT01146652 | Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) | COMPLETED | PHASE3 |
| NCT05516758 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis | TERMINATED | PHASE2 |